Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Retrotope Inc.
DescriptionEncapsulated di-deutero synthetic homolog of linoleic acid ethyl ester
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationAtaxia
Indication DetailsTreat Friedreich's ataxia
Regulatory Designation U.S. - Orphan Drug (Treat Friedreich's ataxia)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today